Buy Altria Stock? There Are 1.69 Billion Reasons to Worry.

Altria Group's cigarette volumes continue to decline, with Q1 2025 production down 13.7% year-over-year and significantly lower than 2020 figures, despite price increases; while the company has maintained rising earnings and dividends through stock buybacks, revenue fell 5.7% year over year, signaling a deeper, underlying problem as Altria struggles to find a replacement for declining cigarette sales, leading to concerns about long-term sustainability.

Analysis

Altria Group (MO) faces a significant challenge as its core cigarette business, which accounts for approximately 88% of its top line and saw 14.2 billion units produced in Q1 2025, experiences persistent volume declines. Cigarette production fell 13.7% year-over-year in Q1 2025 from nearly 16.5 billion units in Q1 2024, and is substantially down from over 25 billion units in Q1 2020. This structural decline in consumer demand has led to a 5.7% year-over-year drop in Q1 2025 revenue to approximately $5.3 billion, compared to nearly $6.4 billion in Q1 2020. While Altria has historically offset volume decreases with price increases, the article suggests this strategy may have reached its limits in sustaining top-line growth. The company has maintained rising earnings per share and dividends, supported by substantial stock buybacks that reduced its share count from 1.758 billion in Q1 2024 to 1.69 billion in Q1 2025. However, these financial engineering tactics appear to be masking the fundamental deterioration in revenue and the company's repeated failures in diversifying away from cigarettes, evidenced by costly unsuccessful investments in Juul and a marijuana company. Despite an attractive 6.7% dividend yield, which is not anticipated to be cut in the near term, the underlying business model is under pressure, and the current strategies are not addressing the core issue of declining sales in its primary market.

Key Decisions for Investors

• Investors should critically evaluate the sustainability of Altria's 6.7% dividend yield and earnings growth, as these are increasingly reliant on share buybacks rather than organic revenue growth, given the 5.7% year-over-year revenue decline in Q1 2025.
• Consider the significant long-term risk posed by the accelerating decline in cigarette volumes, down 13.7% year-over-year, and Altria's historical inability to successfully diversify into alternative revenue streams.
• Income-focused investors, particularly those with a conservative risk profile, should exercise caution and monitor Altria's progress in finding viable replacements for its core cigarette business before initiating or adding to positions, as the current financial tactics may not be sustainable indefinitely.